Xeris Biopharma delivered record Q2 revenue, driven by Recorlev's rapid adoption, and is on track to achieve breakeven in Q3. Recorlev is the primary growth engine, while Gvoke provides steady ...

Haugli projected, "We believe 2026 will be a breakout year for Enclave revenue growth, driven by stronger channel execution, direct enterprise sales and increased awareness of microsegmentation as a ...

Starting a business requires tremendous energy, passion and a clear vision. In the early stages, founders wear multiple hats: sales, operations, finance and culture. As revenue grows, complexity rises ...

At year-end, tech-dominated markets such as Seattle and San Francisco saw annual growth in demand nearing 50 percent, with much more muted growth nationally, according to the Q4 VTS Office Demand ...

As health systems head into 2026 amid margin pressure, policy uncertainty and rising demand, executives are converging around a shared set of priorities. Across responses from CEOs, CFOs and senior ...